Why a Startup Valuation Without a Documented Methodology Does Not Survive Series A Diligence

A company enters a Series A process with a £15 million pre-money valuation expectation. The expectation derives from a previous angel round priced at £6 million, a subsequent year of ARR growth from £200,000 to £750,000, and a comparison to three publicly known competitors whose last rounds were at revenue multiples between 15x and 20x. The investor asks for the valuation methodology. The founding team provides a slide showing the three competitor examples. The investor's analyst applies a revenue multiple analysis to the company's actual ARR and arrives at a valuation range of £9 to £13 million, not £15 million. The gap between the founder's expectation and the investor's analysis is not disputed on the number. It is disputed because the founder has no documented methodology that sets out the basis for their position, the assumptions behind it, and the sensitivity of the range to those assumptions.

WHAT A VALUATION ANALYSIS IS REQUIRED TO CONTAIN

A valuation analysis is a documented derivation of a valuation range using one or more defined methodologies, with stated assumptions, a disclosed peer set where applicable, and a sensitivity analysis on the key inputs. It is not a comparable transaction list. It is not a revenue multiple applied to the current ARR. It is a structured analytical document that produces a defensible range based on a repeatable method.

At Series A stage, the two most applicable methodologies are the comparable company analysis and the venture capital method. The comparable company analysis identifies a peer set of companies at similar stage, sector, and revenue profile and applies the relevant valuation multiples from that peer set to the company's own metrics. The venture capital method calculates the current valuation by working backwards from an assumed exit value and the investor's required return. Both methods produce ranges, not single figures, and both require the assumptions behind them to be stated and testable.

A valuation analysis produced as a single slide in a pitch deck, presenting a multiple applied to ARR without documenting the peer set, the multiple selection rationale, or the sensitivity of the result to the assumed multiple range, is not a valuation analysis. It is a valuation claim.

THE STRUCTURAL REQUIREMENT

The structural requirement that separates a compliant valuation analysis from a valuation claim is the documentation of the methodology in a form that allows an investor to independently replicate the calculation and test the sensitivity of the result to the key assumptions.

For a comparable company analysis, the structural requirements are: identification of the peer set with a stated selection rationale, the source and date of the metric data used for each peer, the specific multiple applied (revenue multiple, ARR multiple, gross profit multiple), the basis for selecting that multiple, and the resulting valuation range for the company being valued at the low, mid, and high end of the peer set multiples.

For the venture capital method, the structural requirements are: the assumed exit value and the methodology by which it was derived, the assumed exit timeline, the investor's required return multiple (or IRR), the assumed dilution from the current round and any subsequent rounds before exit, and the resulting pre-money valuation that would produce the required return at the assumed exit value.

Sensitivity analysis is required on the two or three most material assumptions in whichever methodology is applied. For a comparable company analysis, sensitivity on the revenue multiple range and the ARR figure. For the venture capital method, sensitivity on the exit multiple and the exit timeline.

WHAT THE INVESTOR EVALUATES

A Series A investor evaluating a founder's valuation position will perform their own analysis independently and then compare it to the founder's stated methodology. If the founder has no documented methodology, the investor's analysis becomes the only analysis in the room, and the negotiation proceeds on the investor's terms rather than on a shared evidential basis.

A founder with a documented valuation analysis using the same methodology as the investor — even if the assumptions differ — is in a qualitatively different position. They can identify which specific assumption diverges (the exit multiple, the peer set selection, the timeline), and the negotiation becomes a discussion about specific assumptions rather than a confrontation between a stated position and an undocumented expectation.

An investor who receives a documented valuation analysis from a founder is also evaluating the quality of the analysis itself. A methodology that selects an unrepresentative peer set, applies an unadjusted multiple to a company with materially different gross margin or growth profile from the peers, or fails to document the sensitivity of the result to the most important assumptions will be identified as weak and will reduce rather than strengthen the founder's position.

COMMON STRUCTURAL PROBLEMS

The most common structural problem is the single methodology valuation. A valuation based on a single methodology, presented without cross-referencing against a second approach, is inherently less defensible than a valuation where two methods produce a consistent range. An investor who produces a different result using the venture capital method from the founder's comparable company analysis has no cross-reference to verify which analysis is more reliable. Where two methodologies converge on a similar range, the convergence itself is evidence of defensibility. Where they diverge materially, the divergence identifies the specific assumption that requires discussion.

The second structural problem is an undisclosed peer set. A comparable company analysis that does not name the peer companies it uses is not reproducible and cannot be independently verified. If an investor identifies that the peer set used by the founder included companies with revenue multiples well above the sector median — because they were high growth outliers rather than representative peers — the entire analysis loses credibility. The peer set must be named, the selection criteria must be stated, and where the peer companies are not publicly disclosed in their own valuations, the source of the metric data must be cited.

The third structural problem is the absence of sensitivity analysis. A valuation analysis that presents a single output — a specific pre-money valuation — without disclosing how sensitive that output is to its key assumptions is not complete. An investor who sees a £15 million pre-money valuation without knowing that a one-turn reduction in the revenue multiple assumption produces a £10 million result cannot assess the robustness of the position. The sensitivity analysis is the most honest disclosure in the document, because it shows where the analysis is and is not reliable.

HOW THE FFI STANDARD DEFINES THE REQUIREMENT

The FFI Standard addresses valuation analysis requirements in Book 4. Level 2 compliance requires a documented valuation analysis using at minimum one methodology appropriate to the company's stage, with the methodology documented, the key assumptions stated, and the sensitivity of the valuation range to those assumptions disclosed. Level 3 compliance, applicable to companies preparing for Series B, requires multi-methodology valuation using at minimum two approaches cross-referenced against each other, producing a documented valuation range with sensitivity analysis on the three most material assumptions. Full compliance criteria are published at ffistandard.org/glossary/valuation-analysis/.

THE LAYER ENGAGEMENT

Valuation analysis is a core deliverable of the Raise layer engagement. The engagement produces a valuation analysis using the methodology or methodologies appropriate to the company's stage and sector, with the peer set selection documented and the sensitivity analysis completed to the standard required for investor review. For companies approaching Series B, the Strategy layer engagement extends the valuation analysis to multi-methodology cross-referencing and adds the acquirer analysis comparing strategic and financial buyer dynamics.

The Blueprint Diagnostic at theoakworth.com/portal/blueprint/ identifies whether the absence of a documented valuation methodology is the primary infrastructure gap, or whether the financial model and data room require attention first. For most companies approaching a first institutional raise, the financial model documentation is the prerequisite for a defensible valuation analysis, because the valuation methodology must apply to the financial metrics that the model produces.

RELATED INSIGHTS
- Why a Startup Valuation Without a Documented Methodology Does Not Survive Series A Diligence
- How Valuation Is Derived Using the Venture Capital Method
- The Assumption Layer in a Startup Financial Model Is Not a Tab. It Is a Governance Document
- Cap Table Errors That Surface During Legal Due Diligence and the Infrastructure Required to Resolve Them
- The Headcount Model Most Startup Financial Models Either Miss or Build Incorrectly

Tool: Blueprint Diagnostic